Profile
Matthew D.
Dallas served as an Independent Director at Harvard Apparatus Regenerative Technology, Inc. from 2018 to 2020.
Prior to that, he was the Chief Financial Officer & Treasurer at CoLucid Pharmaceuticals, Inc. from 2015 to 2017 and the Treasurer, Chief Accounting Officer & VP-Finance at AVEO Pharmaceuticals, Inc. from 2011 to 2015.
He also served as the Chief Financial Officer at AVEO Pharmaceuticals, Inc. from 2017 to 2019.
Currently, he is the Chief Financial Officer & Senior Vice President at Zealand Pharma A, a position he has held since 2019.
Mr. Dallas received his undergraduate degree from the University of Tennessee.
Former positions of Matthew D. Dallas
| Companies | Position | End |
|---|---|---|
| ZEALAND PHARMA A/S | Director of Finance/CFO | 2022-08-30 |
| HARVARD APPARATUS REGENERATIVE TECHNOLOGY INC. | Director/Board Member | 2020-02-02 |
| AVEO PHARMACEUTICALS, INC. | Director of Finance/CFO | 2019-09-25 |
| COLUCID PHARMACEUTICALS INC | Director of Finance/CFO | 2017-02-28 |
| AVEO PHARMACEUTICALS, INC. | Comptroller/Controller/Auditor | 2015-02-05 |
Training of Matthew D. Dallas
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
CoLucid Pharmaceuticals, Inc.
CoLucid Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics for neurological disorders | Health Technology |
Harvard Apparatus Regenerative Technology, Inc.
Harvard Apparatus Regenerative Technology, Inc. Medical SpecialtiesHealth Technology Engages in the development and commercialization of medical devices | Health Technology |
University of Tennessee
University of Tennessee Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
AVEO Pharmaceuticals, Inc.
AVEO Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Researches and develops cancer therapeutics | Health Technology |
Zealand Pharma A/S
Zealand Pharma A/S BiotechnologyHealth Technology Operates as a biotechnology company that discovers and develops peptide based medicines | Health Technology |
- Stock Market
- Insiders
- Matthew D. Dallas
















